The Surgical Options

Surgery is where BPH treatment delivers its biggest wins and its most real risks — and where the menu has quietly modernized. This page walks TURP, the laser procedures, and the office-based options through the same honest lens: what each actually does, what relief looks like, what the trade-offs cost, and the red flags that route men into this tier in the first place. Nothing here is a do-it-yourself decision; the goal is a better-informed conversation with a urologist.

Who Crosses the Threshold

Most men with BPH never have a procedure — the watchful-waiting tier holds for the majority, and the medication ladder carries most of the rest. Surgery enters the conversation for a specific set of reasons: symptoms that stay bothersome after a genuine trial of medication, or complications of obstruction itself — repeated retention episodes, recurrent infections, bladder stones, or kidney strain from back pressure. The decision frame is the same one used at every tier: match the intervention to the bother, and never operate on a scan. A large prostate with no symptoms remains a fact, not an indication.

TURP: The Benchmark

Transurethral resection of the prostate — TURP — has been the reference procedure for decades, and its results are the yardstick every newer technique is measured against. Through a scope passed up the urethra, the surgeon carves away the obstructing transition-zone tissue in chips, reopening the channel. The payoff is real and well documented: pooled analyses report mean symptom-score improvements on the order of 70% — the largest average relief in the menu — with results that endure for years (Cornu et al., European Urology 2015). In the landmark VA trial, men randomized to TURP gained substantially more flow and symptom improvement than men randomized to watchful waiting (Wasson et al., NEJM 1995).

The costs, stated plainly. Bleeding requiring transfusion in about 3% of cases in a prospective series of 10,654 patients, with serious complications and mortality rare — on the order of a fraction of one percent (Reich et al., Journal of Urology 2008). A hospital stay and a catheter for a day or more, with a recovery window measured in weeks for full comfort. And the trade men consistently report as the biggest: retrograde ejaculation in the majority — roughly two-thirds of men — orgasm without semen, permanent and health-neutral but emotionally significant. Reoperation rates are on the order of one in ten within a decade as tissue regrows. TURP is the most-studied, most effective, and least side-effect-free option in the tier; all three statements are true at once.

The Laser Era

Lasers solved TURP's two sharpest problems — bleeding and the limits on gland size. HoLEP (holmium laser enucleation) uses the laser to shell out the obstructing lobes whole, like taking the fruit out of an orange, then grinds them for removal. It matches TURP's relief, works for any gland size — including the very large prostates that once required open surgery — and bleeds far less, with durable results documented at six years (Gilling et al., European Urology 2008). Its honest cost is a steep learning curve for surgeons, which is why availability varies by center. GreenLight photo-vaporization simply vaporizes the tissue instead of removing it: less durable in very large glands, but with minimal bleeding — a frequent choice for men on blood thinners who cannot pause them safely. Between the two, enucleation removes; vaporization dissolves. Both convert a two-day hospital event into something closer to an overnight or same-day stay.

The Office-Based Options

The newest rung of the tier moves treatment out of the operating room entirely. UroLift implants small permanent clips that pin the obstructing lobes apart — no tissue is removed, no catheter for most men, and ejaculation is essentially preserved. The trade is durability: its pivotal study reported about 14% of men returning for another treatment within five years (Roehrborn et al., Canadian Journal of Urology 2017). Rezum injects steam into the prostate, thermally destroying a small volume of obstructing tissue over a few seconds; ejaculation is preserved in the large majority, recovery is days, and early retreatment rates are lower than for the clip approach — but the relief is smaller than TURP's and the longest-term data are still maturing. Both fit the same profile: a man who wants real symptom relief, accepts less of it, and refuses to pay the ejaculation price. That is a legitimate preference, and the honest summary is a swap — less relief and more retreatments in exchange for preserved ejaculation and a light recovery.

The Relief-to-Risk Table

Red Flags That Route You Here

Some findings skip the waiting and the medications entirely — they mean evaluation now, and often they lead directly to this tier:

• 🩸 Blood in the urine. Visible or microscopic — prompt evaluation, and the workup considers the bladder and kidneys, not just the prostate. Urinary-tract cancers often announce themselves this way, so the first job is ruling out worse actors than BPH.
• 🚫 Inability to urinate at all. Acute retention — bladder full, nothing drains, pain builds — is an emergency: catheterization now, plumbing decisions after. One retention episode permanently changes the treatment conversation.
• 🔁 Recurrent urinary infections. Repeated UTIs in a man usually mean the bladder is not emptying — a structural problem with a structural fix.
• 🪨 Bladder stones. Stones form in urine that pools; they are a sign of chronic incomplete emptying and an indication on their own.
• 🫘 Kidney strain. Rising creatinine or flank pain suggests back-pressure is reaching the kidneys — the one path by which BPH becomes a whole-body problem. This is why the watchful tier checks kidney function yearly.

Questions, Answered Briefly

• 🔪 Is TURP still the default? It is the benchmark and the most-studied option, but not the automatic choice anymore — lasers now match it with less bleeding, and the office procedures exist precisely for men who will not accept the ejaculation trade.
• 💨 Is dry ejaculation certain after surgery? After TURP, HoLEP, and simple prostatectomy it is the majority outcome. After UroLift and Rezum it is largely avoided. If ejaculation matters to you, say so — it changes the menu.
• ⏱️ How long does relief last? TURP's results are measured in years to a decade-plus; about one in ten men need a repeat within ten years. The office procedures have higher retreatment rates — in the mid-teens percent at five years for UroLift in its pivotal study.
• 💉 I take blood thinners — what then? GreenLight is frequently chosen for exactly this situation because it bleeds least, but the decision belongs to the team managing both your anticoagulation and your surgery. Never pause blood thinners on your own.
• 🌙 Will surgery fix my night waking? It often reduces nocturia — but not always, because nocturia has co-authors. If untreated sleep apnea or evening fluids are doing part of the waking, the prostate procedure will not silence them. Set expectations before, not after.

Related Topics